Med-Chemist : "Quintessential Medicinal Chemistry"
Thursday, October 22, 2015
Tris Pharma announces launch of generic TUSSIONEX
›
Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced the launch of Tris-labeled ...
Wednesday, October 21, 2015
Beta-catenin shows treatment target potential for TKI-resistant CML
›
Nuclear β-catenin could be a treatment target for patients whose chronic myeloid leukaemia (CML) is resistant to tyrosine kinase inhi...
Tuesday, October 20, 2015
AbbVie reports positive results from ABT-494 Phase 2 clinical trials in patients with rheumatoid arthritis
›
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced results from two Phase 2 clinical trials evaluating its inves...
Monday, October 19, 2015
Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment
›
Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved the new d...
1 comment:
Friday, October 16, 2015
Allergan releases generic INVEGA (paliperidone extended-release tablets) in the U.S.
›
In continuation oof my update on paliperidone Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced th...
Wednesday, October 14, 2015
TUM scientists develop molecules that could pave way for new treatments to fight Alzheimer's, diabetes
›
When proteins change their structure and clump together, formation of amyloid fibrils and plaques may occur. Such 'misfolding' and...
Tuesday, October 13, 2015
SMC approves Bayer's Xofigo for treatment of castration-resistant prostate cancer in NHS Scotland
›
The Scottish Medicines Consortium (SMC) has today announced that Xofigo® (radium-223 dichloride) has been accepted for use within NHS Scotla...
Patients with advanced kidney cancer benefit from cabozantinib treatment
›
In continuation of my update on cabozantinib Patients with advanced kidney cancer live for nearly twice as long without their dise...
Monday, October 12, 2015
Dried plum diet may help reduce colon cancer risk
›
Researchers from Texas A&M University and the University of North Carolina have shown a diet containing dried plums can positively a...
Wednesday, October 7, 2015
The Nobel Prize in Chemistry 2015
›
The cells’ toolbox for DNA repair The Nobel Prize in Chemistry 2015 is awarded to Tomas Lindahl, Paul Modrich and Aziz Sancar for having map...
1 comment:
S1 Biopharma supports FDA's approval of flibanserin for women living with HSDD
›
Approval of flibanserin by the U.S. Food and Drug Administration (FDA) was a significant advancement for women's health, addres...
Tuesday, October 6, 2015
STA inks license and commercialisation agreement with PharmaMar for APLIDIN (plitidepsin)
›
Australian biopharmaceutical company Specialised Therapeutics Australia has struck an exclusive license and commercialisation agreemen...
Monday, October 5, 2015
AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion
›
AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced that a Phase 2 trial of its investigational medicine venetocla...
Friday, October 2, 2015
Envarsus XR granted FDA orphan drug designation for prophylaxis of organ rejection in kidney transplant patients
›
Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that Envarsus ® XR was granted Orphan Drug status by the U.S. F...
Thursday, October 1, 2015
AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion
›
Venetoclax, also known as ABT-199 or GDC0199, is an orally bioavailable, selective small molecule inhibitor of the anti-apoptotic pr...
‹
›
Home
View web version